Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q2 2023 Substance Use Disorder Update

Skip to the end of the Expertise Menu

Q2 2023 Substance Use Disorder Update

Dealmaking activity in the Substance Use Disorder (SUD) space improved slightly in Q2 2023 relative to Q1 2023.  Deal flow is still down significantly from the elevated 2021 and 2022 periods. Annualized year-to-date transaction volume is down 26% from 2022.  Restricted lending markets, inflation, and continued labor shortages are forcing industry consolidators to put M&A on pause and reallocate resources to internal organic growth and de novo initiatives.

Notable Q2 2023 deal-flow included two new platform investments. Banyan Treatment Centers and Your Behavioral Health both received investment from leading private equity firms, establishing the two newest SUD consolidators. These transactions indicate continued investor interest in the SUD space despite sluggish transaction volume in the current market.

To print and download the full  Substance Use Disorder Update report, please click below…

[holo_button icon=”/wp-content/uploads/2023/07/Q2-2023-Newsletter-Package_Substance-Abuse.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]